U.S Physical Therapy Operating Income 2010-2024 | USPH

U.S Physical Therapy operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
U.S Physical Therapy Annual Operating Income
(Millions of US $)
2023 $52
2022 $57
2021 $71
2020 $52
2019 $67
2018 $60
2017 $55
2016 $50
2015 $47
2014 $46
2013 $39
2012 $38
2011 $31
2010 $33
2009 $28
U.S Physical Therapy Quarterly Operating Income
(Millions of US $)
2024-09-30 $15
2024-06-30 $20
2024-03-31 $14
2023-12-31 $-1
2023-09-30 $16
2023-06-30 $20
2023-03-31 $17
2022-12-31 $7
2022-09-30 $15
2022-06-30 $20
2022-03-31 $15
2021-12-31 $16
2021-09-30 $17
2021-06-30 $22
2021-03-31 $15
2020-12-31 $18
2020-09-30 $20
2020-06-30 $10
2020-03-31 $4
2019-12-31 $15
2019-09-30 $17
2019-06-30 $20
2019-03-31 $15
2018-12-31 $15
2018-09-30 $15
2018-06-30 $17
2018-03-31 $13
2017-12-31 $14
2017-09-30 $13
2017-06-30 $16
2017-03-31 $12
2016-12-31 $11
2016-09-30 $12
2016-06-30 $15
2016-03-31 $11
2015-12-31 $13
2015-09-30 $12
2015-06-30 $14
2015-03-31 $9
2014-12-31 $11
2014-09-30 $11
2014-06-30 $14
2014-03-31 $10
2013-12-31 $9
2013-09-30 $10
2013-06-30 $11
2013-03-31 $8
2012-12-31 $8
2012-09-30 $10
2012-06-30 $11
2012-03-31 $10
2011-12-31 $3
2011-09-30 $9
2011-06-30 $11
2011-03-31 $9
2010-12-31 $8
2010-09-30 $9
2010-06-30 $10
2010-03-31 $7
2009-12-31 $6
2009-09-30 $7
2009-06-30 $8
2009-03-31 $6
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.337B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00